Michael E. Severino

550 total citations
10 papers, 457 citations indexed

About

Michael E. Severino is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Michael E. Severino has authored 10 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Michael E. Severino's work include Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers) and HIV Research and Treatment (2 papers). Michael E. Severino is often cited by papers focused on Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers) and HIV Research and Treatment (2 papers). Michael E. Severino collaborates with scholars based in United States, Italy and Hungary. Michael E. Severino's co-authors include Martin Schlumberger, R. Monier, Suàrez Hg, Bernard Caillou, M Tubiana, C Parmentier, Otto O. Yang, Phuong Nguyen, D.J. Devlin and Maha Karnoub and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.

In The Last Decade

Michael E. Severino

9 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Severino United States 7 202 187 138 106 101 10 457
Antonella Balsamo Italy 14 100 0.5× 212 1.1× 185 1.3× 40 0.4× 90 0.9× 23 472
Ayşe Özer Türkiye 14 53 0.3× 152 0.8× 225 1.6× 32 0.3× 23 0.2× 31 538
Pietro Gangemi Italy 12 177 0.9× 164 0.9× 241 1.7× 44 0.4× 93 0.9× 15 513
I. Sklenar Switzerland 13 32 0.2× 94 0.5× 132 1.0× 37 0.3× 59 0.6× 23 375
Yu Heng China 15 133 0.7× 200 1.1× 212 1.5× 177 1.7× 113 1.1× 59 651
Alison Taylor United Kingdom 13 84 0.4× 22 0.1× 124 0.9× 381 3.6× 76 0.8× 15 577
Eric Casal Ide Italy 14 331 1.6× 104 0.6× 129 0.9× 131 1.2× 20 0.2× 18 486
Baixin Zhu United States 11 512 2.5× 71 0.4× 212 1.5× 122 1.2× 72 0.7× 12 692
О. С. Ларін United States 11 420 2.1× 278 1.5× 339 2.5× 95 0.9× 45 0.4× 32 727
Maral Saadati Germany 10 66 0.3× 132 0.7× 180 1.3× 54 0.5× 92 0.9× 22 445

Countries citing papers authored by Michael E. Severino

Since Specialization
Citations

This map shows the geographic impact of Michael E. Severino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Severino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Severino more than expected).

Fields of papers citing papers by Michael E. Severino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Severino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Severino. The network helps show where Michael E. Severino may publish in the future.

Co-authorship network of co-authors of Michael E. Severino

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Severino. A scholar is included among the top collaborators of Michael E. Severino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Severino. Michael E. Severino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Balzamino, Bijorn Omar, Michael E. Severino, Concetta Cafiero, et al.. (2025). The Zebrafish as a Model for Ocular Translational Research: From Retinal Repair to Regeneration. Cells. 14(17). 1405–1405.
2.
Severino, Michael E., Robert DuBose, & Scott D. Patterson. (2006). A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development.. PubMed. 9(12). 849–53. 6 indexed citations
3.
Hardwick, James S., Yi Yang, Chunsheng Zhang, et al.. (2005). Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling. Molecular Cancer Therapeutics. 4(3). 413–425. 24 indexed citations
4.
Simon, Jason S., Maha Karnoub, D.J. Devlin, et al.. (2005). Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment. Genomics. 86(6). 648–656. 103 indexed citations
5.
Severino, Michael E., Phuong Thi Nguyen Sarkis, Bruce D. Walker, & Otto O. Yang. (2003). Chimeric immune receptor T cells bypass class I requirements and recognize multiple cell types relevant in HIV-1 infection. Virology. 306(2). 371–375. 6 indexed citations
6.
Yang, Otto O., Frederick Racke, Phuong Nguyen, et al.. (2000). CD1d on Myeloid Dendritic Cells Stimulates Cytokine Secretion from and Cytolytic Activity of Vα24JαQ T Cells: A Feedback Mechanism for Immune Regulation. The Journal of Immunology. 165(7). 3756–3762. 59 indexed citations
7.
Severino, Michael E., Nikolaos V. Sipsas, Phuong Nguyen, et al.. (2000). Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary CD4+T Lymphocytes, Monocytes, and Dendritic Cells by Cytotoxic T Lymphocytes. Journal of Virology. 74(14). 6695–6699. 17 indexed citations
8.
Severino, Michael E., et al.. (1993). Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.. PubMed. 25(1 Pt 1). 520–3. 7 indexed citations
9.
Sartor, Oliver, R Moriuchi, J H Sameshima, et al.. (1992). Diverse biologic properties imparted by the c-fgr proto-oncogene.. Journal of Biological Chemistry. 267(5). 3460–3465. 16 indexed citations
10.
Hg, Suàrez, Michael E. Severino, Bernard Caillou, et al.. (1990). Presence of mutations in all three ras genes in human thyroid tumors.. PubMed. 5(4). 565–70. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026